The orthopaedic prosthetic devices market is expected to grow at a 4.7% CAGR during the forecast period, from US$ 1.9 billion in 2019 to US$ 2.8 billion by 2027. Orthopedic Prosthetics are an external mechanical devices that replaces a missing body part in the skeletal system. Its acts as a prevention or correction of injuries …
Category Archives: Healthcare Trends
3D Printed Surgical Models Market Size is anticipated to be US$ 1731.9 million through 2032
The 3D printed surgical models market is expected to see a prodigious CAGR of 14.7%, and is projected to increase from US$ 347.5 million in 2021 to US$ 1731.9 million by 2032. The use of 3D printed surgical models in the healthcare industry for planning tumor excision, endovascular aneurysm repair, and the treatment of trauma injuries in orthopedic surgery has improved …
Medical Billing Outsourcing Market is projected to increase at a CAGR of around 16% by 2032
The Medical Billing Outsourcing Market revenues were estimated at US$ 11.1 Billion in 2021 and is anticipated to grow at a CAGR of 16% from 2022 to 2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 55.6 Billion. To Get Sample …
Central Pain Syndrome Management Market is expected to grow most profitably in Asia Pacific | Says FMI Analyst
A recently published study by FMI expects the global Central Pain Syndrome Management Market to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the World Health Organization (WHO), the share of the world’s …
Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market is expected to reach US$ 233.05 Billion by 2033
The market for Hutchinson Gilford progeria syndrome is anticipated to reach a market value of US$ 103.07 billion in 2023 and to reach US$ 233.05 billion by 2033, at a CAGR of 8.5%. The world’s expanding population, which is also leading to an increase in progeria cases, can be blamed for the expansion of the …
Congenital Hyperinsulinism Treatment Market is expected to reach US$ 179.08 Million by 2033 | FMI
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in the historical period …
Ablation Devices Market is expected to reach a valuation of US$ 12.6 Billion by 2033
The global ablation devices market is anticipated to reach US$ 4.4 Billion in 2023. The market could grow at a promising CAGR of 11.1%, attaining a market valuation of US$ 12.6 Billion by 2033. For In-depth insights, Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11254 Key Factors Aiding the Growth of the Ablation Devices Market Between 2023 and 2033: Wide adoption of minimally …
Global Hyperpigmentation Treatment Market to exhibit a CAGR of 7.4% until 2033
The global hyperpigmentation treatment market is predicted to grow US$ 11.84 billion by 2033 at a compound annual growth rate (CAGR) of 7.4%. Skin hyperpigmentation results from a slight decrease in melanin synthesis. Laser treatment, cosmeceuticals, and chemical peels can all be used to treat hyperpigmentation disorders. The global hyperpigmentation market is also being influenced …
Continue reading “Global Hyperpigmentation Treatment Market to exhibit a CAGR of 7.4% until 2033”
Multi-Parameter Patient Monitoring Market is expected to reach US$ 7.2 billion by 2033
In 2023, the multi-parameter patient monitoring market is expected to be worth US$ 4.8 billion. It is expected to reach US$ 7.2 billion by 2033, growing at a CAGR of 4.0% between 2023 and 2033. In intensive care units, emergency departments, and general wards, home monitoring devices are commonly used to monitor continuous vital signs …
Dystrophic Epidermolysis Bullosa Management Market to reach US$ 787.8 Million by 2033
According to Future Market Insights, global dystrophic epidermolysis bullosa management is expected to grow at a CAGR of 5.7% between 2023 and 2033, reaching US$ 787.8 Million in 2033. With a rise in the prevalence of dystrophic epidermolysis bullosa, coupled with increased research for treating this condition, global dystrophic epidermolysis bullosa treatment is expected to …